Comprehending EU's Strategy for Combatting Falsified Medicines
Falsified medicines pose a significant threat to public health, undermining trust in the healthcare system and jeopardizing patient well-being. Recognizing the gravity of this issue, the European Union (EU) has implemented a multifaceted strategy to combat the distribution and marketing of falsified medicinal products within its member states.